Trials / Completed
CompletedNCT00307580
Cathflo Activase Pediatric Study
Cathflo Activase (Alteplase) Pediatric Study (CAPS)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
This was a Phase IV, open-label, single-arm, multicenter trial that was to be conducted at \~60 sites in the United States. Approximately 300 pediatric subjects with dysfunctional CVADs (including catheters with valves, multiple lumens, umbilical catheters, and implanted ports) were to be treated with up to two serially instilled doses of Cathflo Activase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cathflo Activase (Alteplase) |
Timeline
- Start date
- 2002-04-01
- Completion
- 2003-05-01
- First posted
- 2006-03-28
- Last updated
- 2014-04-09
Source: ClinicalTrials.gov record NCT00307580. Inclusion in this directory is not an endorsement.